Advisory Research Inc Moderna, Inc. Transaction History

Advisory Research Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $497,620 - $924,921	-3,935 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$225.82 - $368.51 $307,792 - $502,279	1,363 Added 52.99%	3,935 $999,000
Q3 2021 Nov 12, 2021	SELL	$221.9 - $484.47 $1.33 Million - $2.89 Million	-5,972 Reduced 69.9%	2,572 $990,000
Q2 2021 Aug 16, 2021	SELL	$129.91 - $234.98 $413,373 - $747,706	-3,182 Reduced 27.14%	8,544 $2.01 Million
Q1 2021 May 12, 2021	BUY	$109.18 - $185.98 $306,468 - $522,045	2,807 Added 31.47%	11,726 $1.54 Million
Q4 2020 Feb 12, 2021	SELL	$65.74 - $169.86 $391,547 - $1.01 Million	-5,956 Reduced 40.04%	8,919 $932,000
Q3 2020 Nov 12, 2020	SELL	$54.34 - $94.85 $263,005 - $459,074	-4,840 Reduced 24.55%	14,875 $1.05 Million
Q2 2020 Aug 13, 2020	SELL	$29.67 - $80.0 $155,767 - $420,000	-5,250 Reduced 21.03%	19,715 $1.27 Million
Q1 2020 May 12, 2020	SELL	$17.78 - $31.58 $248,155 - $440,762	-13,957 Reduced 35.86%	24,965 $748,000
Q4 2019 Feb 11, 2020	BUY	$13.93 - $21.28 $274,769 - $419,748	19,725 Added 102.75%	38,922 $761,000
Q3 2019 Nov 12, 2019	BUY	$12.26 - $18.07 $235,355 - $346,889	19,197 New	19,197 $306,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

Stay updated on Advisory Research Inc with notifications on news.